Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2005

01-10-2005 | Epidemiology

Estrogen Metabolizing Polymorphisms and Breast Cancer Risk Among Older White Women

Authors: Francesmary Modugno, Joseph M. Zmuda, Douglas Potter, Chao Cai, Elad Ziv, Steven R. Cummings, Katie L. Stone, Phillip A. Morin, Deborah Greene, Jane A. Cauley

Published in: Breast Cancer Research and Treatment | Issue 3/2005

Login to get access
Metadata
Title
Estrogen Metabolizing Polymorphisms and Breast Cancer Risk Among Older White Women
Authors
Francesmary Modugno
Joseph M. Zmuda
Douglas Potter
Chao Cai
Elad Ziv
Steven R. Cummings
Katie L. Stone
Phillip A. Morin
Deborah Greene
Jane A. Cauley
Publication date
01-10-2005
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 3/2005
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-005-5347-8

Other articles of this Issue 3/2005

Breast Cancer Research and Treatment 3/2005 Go to the issue

Report

High Grade Primary Breast Lymphoma: is it a Different Clinical Entity?

Report

Bone Mineral Density and Lipid Changes During 5 Years of Follow-up in a Study of Prevention of Breast Cancer with Toremifene in Healthy, High-risk Pre- and Post-menopausal Women

Clinical Trial

Short Versus Long-term Postoperative Drainage of the Axilla After Axillary Lymph Node Dissection. A Prospective Randomized Study

Report

Follow-up Cost of Breast Cancer Patients with Localized Disease After Primary Treatment: a Randomized Trial

Report

Cyclic Induction of Senescence with Intermittent AZT Treatment Accelerates both Apoptosis and Telomere Loss

Report

Tubular Carcinoma of the Breast: a Retrospective Analysis and Review of the Literature
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits